Scientists identify possible new heritable marker for retinoblastoma
January 27th, 2010 - 6:35 pm ICT by ANI ( Leave a comment )Washington, Jan 27 (ANI): A new research has found what may be a possible new heritable marker for retinoblastoma, a pediatric eye cancer triggered by the loss or mutation of both copies of the retinoblastoma gene.
Scientists at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have disclosed the possible role of inactivation of the 16INK4A gene in the development of retinoblastoma.
Antonio Giordano, lead author of the study and director of the Sbarro Institute and the Center for Biotechnology at Temple, said: “The finding that the expression of p16INK4A was reduced both in patients and their parents in our samples suggests that this alteration could be a novel marker of an inheritable susceptibility to retinoblastoma in young patients.”
Researchers examined the 16INK4A gene because of its suspected role in the progression of retinoblastoma and its involvement in a predisposition to familial cancer.
The researchers analysed blood samples of 29 patients and their parents. They found low to moderate 16INK4A protein expression in 5 of 11 retinoblastoma tumor specimens. They also discovered reduced p16INK4a RNA expression in blood, correlated with the demethylation, or reduction, of the p16INK4a gene, in 16 of 29 of retinoblastoma patients relative to normal controls.
Joan O’Brien, Chair of the Department of Ophthalmology at the University of Pennsylvania and Director of the Scheie Eye Institute, said: “Intriguingly, the researchers also found reduced expression in at least one parent among 9 of the 16 (56%) patients with reduced p16INK4a RNA expression. Dr. Giordano and his coworkers suggest that this finding could represent a marker for retinoblastoma susceptibility.”
O’Brien added: “Confirmation of this hypothesis by future studies would enhance our understanding of genetic and epigenetic events contributing to this disease.”
The findings of the study have been published in the latest edition of the Journal of Cellular Physiology. (ANI)
- Single shot of morphine has long lasting effects on testosterone levels - Nov 04, 2010
- New process to 'program' cancer cell death created - Sep 08, 2010
- Molecule engineered to attack HIV shows positive results - Jan 20, 2011
- Scientists discover cancer treatment in 'junk DNA' - Sep 29, 2010
- Chinese scientists make headway in leprosy prevention - Jan 30, 2012
- Mom loses custody battle over breast cancer - May 10, 2011
- Statin may help fight HIV - Feb 17, 2011
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- New technique to visualize gene expression in mammalian cells found - Jan 17, 2011
- MicroRNAs could increase amputation risk in diabetics - Jan 13, 2011
- Study examines gene that may hold key to reducing spread of oral cancer - Jul 24, 2010
- Gene makes ovarian cancer resistant to chemotherapy - Mar 03, 2011
- Genetic change helps lung tumors spread to other parts of the body - Apr 07, 2011
- Scientists find eye development error causing cataracts, glaucoma - Mar 25, 2011
- Endometrial cancer gene identified - Apr 18, 2011
Tags: antonio giordano, blood samples, cancer research, demethylation, epigenetic events, familial cancer, future studies, joan o brien, molecular medicine, pediatric eye cancer, protein expression, retinoblastoma gene, retinoblastoma tumor, sbarro, scheie eye institute, siena italy, temple university in philadelphia pa, university in philadelphia, university of pennsylvania, university of siena
